Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00177528 · ClinicalTrials.gov registry record · Phase 4
Safety and Efficacy of Venlafaxine XR in Elderly Patients With Major Depression
A Phase 4 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
NCT00177528 is a Phase 4 study that has completed, run by University of Pittsburgh. The registered enrollment target is 70 participants.
The verdict
NCT00177528, a Phase 4 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
Study Summary
This research study is to evaluate the safety and usefulness of venlafaxine-XR in the treatment of major depression in the elderly.
Interventions
- DRUG venlafaxine-XR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2000-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00177528
The ClinicalTrials.gov registry entry for NCT00177528 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which venlafaxine-XR is the first listed.
NCT00177528 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00177528 about?
NCT00177528 is a clinical study titled "Safety and Efficacy of Venlafaxine XR in Elderly Patients With Major Depression". This research study is to evaluate the safety and usefulness of venlafaxine-XR in the treatment of major depression in the elderly.
What is the current status of trial NCT00177528?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2000-10.
What interventions are being tested in trial NCT00177528?
The interventions under investigation include: venlafaxine-XR (DRUG).
Who is sponsoring clinical trial NCT00177528?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.